Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate

Rhoptry proteins have been extensively shown to be important in invasion and parasitophorous vacuole (PV) formation. This work evaluates the immunogenicity and protective efficacy of Plasmodium vivax RAP2 in the non-human Aotus primate model, when expressed as a recombinant molecule in E. coli and f...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23450
Acceso en línea:
https://doi.org/10.1016/j.vaccine.2009.02.083
https://repository.urosario.edu.co/handle/10336/23450
Palabra clave:
Alum hydroxide
Antibody
Clindamycin
Cytokine
Freund adjuvant
Gamma interferon
Immunological adjuvant
Interleukin 2
Interleukin 4
Interleukin 5
Interleukin 6
Malaria vaccine
Primaquine
Pyrimethamine
Quinine sulfate
Recombinant protein pvrap2 vaccine
Recombinant rhoptry associated protein 2 vaccine
Sulfadoxine
Tumor necrosis factor
Unclassified drug
Animal experiment
Animal model
Antibody response
Antibody specificity
Antibody titer
Aotus nancymaae
Article
Cell vacuole
Cellular immunity
Controlled study
Cytokine production
Drug efficacy
Enzyme linked immunosorbent assay
Escherichia coli
Humoral immunity
Immune response
Immunization
Immunofluorescence
Immunogenicity
Monkey
Nonhuman
Parasitemia
Plasmodium vivax
Priority journal
Protection
Protein expression
Western blotting
Animals
Aotidae
Immunogenetic processes
Malaria vaccines
Plasmodium vivax
Protozoan proteins
Immune response
Plasmodium vivax
Rhoptry-associated protein
Vaccine candidate
animal
Disease models
Rights
License
Abierto (Texto Completo)
id EDOCUR2_34710fb34531d0c07f3a891b5b3b8889
oai_identifier_str oai:repository.urosario.edu.co:10336/23450
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 00205185-8f0a-42f9-b55f-92d6b99f5c4a-1914e954b-fc69-43d1-8b0b-ddda45ad991a-1e5f1cbf1-23e3-4d81-8133-988255004a6e-1efcdd5ad-3279-498e-aa37-f283c1e8305f-1c7154e3c-16ca-49f3-916d-cd23e8c82ecb-1ca73c9c8-6215-43ca-b9cc-d7e3d2abe46a-11609eecf-af24-4e1e-9f07-4f944f55908f-1faaf745c-61cf-4170-a36f-07c6154b327c-179653065-12020-05-26T00:02:07Z2020-05-26T00:02:07Z2009Rhoptry proteins have been extensively shown to be important in invasion and parasitophorous vacuole (PV) formation. This work evaluates the immunogenicity and protective efficacy of Plasmodium vivax RAP2 in the non-human Aotus primate model, when expressed as a recombinant molecule in E. coli and formulated in Freund and Alum hydroxide adjuvants. Our results show that rPvRAP2 is immunogenic in both formulations, finding a trend of higher cytokine levels in immunized monkeys, specially in IL-4 levels (using Freund's adjuvant) and IL-5 (using Alum hydroxide). RAP2 is suggested as a P. vivax-vaccine candidate since immunized monkeys exhibited lower parasitemias than control groups after being experimentally challenged with the P. vivax VCG-I strain. © 2009 Elsevier Ltd. All rights reserved.application/pdfhttps://doi.org/10.1016/j.vaccine.2009.02.0830264410X13588745https://repository.urosario.edu.co/handle/10336/23450eng2876No. 212870VaccineVol. 27Vaccine, ISSN:0264410X, 13588745, Vol.27, No.21 (2009); pp. 2870-2876https://www.scopus.com/inward/record.uri?eid=2-s2.0-64449088031&doi=10.1016%2fj.vaccine.2009.02.083&partnerID=40&md5=b9f51df638ac77777d83049a0da4c0e4Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAlum hydroxideAntibodyClindamycinCytokineFreund adjuvantGamma interferonImmunological adjuvantInterleukin 2Interleukin 4Interleukin 5Interleukin 6Malaria vaccinePrimaquinePyrimethamineQuinine sulfateRecombinant protein pvrap2 vaccineRecombinant rhoptry associated protein 2 vaccineSulfadoxineTumor necrosis factorUnclassified drugAnimal experimentAnimal modelAntibody responseAntibody specificityAntibody titerAotus nancymaaeArticleCell vacuoleCellular immunityControlled studyCytokine productionDrug efficacyEnzyme linked immunosorbent assayEscherichia coliHumoral immunityImmune responseImmunizationImmunofluorescenceImmunogenicityMonkeyNonhumanParasitemiaPlasmodium vivaxPriority journalProtectionProtein expressionWestern blottingAnimalsAotidaeImmunogenetic processesMalaria vaccinesPlasmodium vivaxProtozoan proteinsImmune responsePlasmodium vivaxRhoptry-associated proteinVaccine candidateanimalDisease modelsImmunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidatearticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Rojas-Caraballo, JoseMongui, AlvaroGiraldo, Manuel A.Delgado, GabrielaGranados, DianaMillan-Cortes, DianaMartinez, PaolaRodriguez, RaulPatarroyo, Manuel A.ORIGINALImmunogenicity_and_protection_inducing_a.pdfapplication/pdf4683360https://repository.urosario.edu.co/bitstreams/9f625b72-8201-4c07-8d47-53c05e80084b/download0b2501e83b871d4268fbae425ac4ecbbMD51TEXTImmunogenicity_and_protection_inducing_a.pdf.txtImmunogenicity_and_protection_inducing_a.pdf.txtExtracted texttext/plain42626https://repository.urosario.edu.co/bitstreams/7e1a39a1-ee4c-47ef-900c-6a51ce58c75c/downloadcd63baecec7fbd92d92b3778fb6635e4MD52THUMBNAILImmunogenicity_and_protection_inducing_a.pdf.jpgImmunogenicity_and_protection_inducing_a.pdf.jpgGenerated Thumbnailimage/jpeg4849https://repository.urosario.edu.co/bitstreams/bfd7f937-4a07-46f3-852b-dfa00a100d1c/download345ef783fd0d66617288ac6db103a580MD5310336/23450oai:repository.urosario.edu.co:10336/234502022-05-02 07:37:21.515686https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
title Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
spellingShingle Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
Alum hydroxide
Antibody
Clindamycin
Cytokine
Freund adjuvant
Gamma interferon
Immunological adjuvant
Interleukin 2
Interleukin 4
Interleukin 5
Interleukin 6
Malaria vaccine
Primaquine
Pyrimethamine
Quinine sulfate
Recombinant protein pvrap2 vaccine
Recombinant rhoptry associated protein 2 vaccine
Sulfadoxine
Tumor necrosis factor
Unclassified drug
Animal experiment
Animal model
Antibody response
Antibody specificity
Antibody titer
Aotus nancymaae
Article
Cell vacuole
Cellular immunity
Controlled study
Cytokine production
Drug efficacy
Enzyme linked immunosorbent assay
Escherichia coli
Humoral immunity
Immune response
Immunization
Immunofluorescence
Immunogenicity
Monkey
Nonhuman
Parasitemia
Plasmodium vivax
Priority journal
Protection
Protein expression
Western blotting
Animals
Aotidae
Immunogenetic processes
Malaria vaccines
Plasmodium vivax
Protozoan proteins
Immune response
Plasmodium vivax
Rhoptry-associated protein
Vaccine candidate
animal
Disease models
title_short Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
title_full Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
title_fullStr Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
title_full_unstemmed Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
title_sort Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
dc.subject.keyword.spa.fl_str_mv Alum hydroxide
Antibody
Clindamycin
Cytokine
Freund adjuvant
Gamma interferon
Immunological adjuvant
Interleukin 2
Interleukin 4
Interleukin 5
Interleukin 6
Malaria vaccine
Primaquine
Pyrimethamine
Quinine sulfate
Recombinant protein pvrap2 vaccine
Recombinant rhoptry associated protein 2 vaccine
Sulfadoxine
Tumor necrosis factor
Unclassified drug
Animal experiment
Animal model
Antibody response
Antibody specificity
Antibody titer
Aotus nancymaae
Article
Cell vacuole
Cellular immunity
Controlled study
Cytokine production
Drug efficacy
Enzyme linked immunosorbent assay
Escherichia coli
Humoral immunity
Immune response
Immunization
Immunofluorescence
Immunogenicity
Monkey
Nonhuman
Parasitemia
Plasmodium vivax
Priority journal
Protection
Protein expression
Western blotting
Animals
Aotidae
Immunogenetic processes
Malaria vaccines
Plasmodium vivax
Protozoan proteins
Immune response
Plasmodium vivax
Rhoptry-associated protein
Vaccine candidate
topic Alum hydroxide
Antibody
Clindamycin
Cytokine
Freund adjuvant
Gamma interferon
Immunological adjuvant
Interleukin 2
Interleukin 4
Interleukin 5
Interleukin 6
Malaria vaccine
Primaquine
Pyrimethamine
Quinine sulfate
Recombinant protein pvrap2 vaccine
Recombinant rhoptry associated protein 2 vaccine
Sulfadoxine
Tumor necrosis factor
Unclassified drug
Animal experiment
Animal model
Antibody response
Antibody specificity
Antibody titer
Aotus nancymaae
Article
Cell vacuole
Cellular immunity
Controlled study
Cytokine production
Drug efficacy
Enzyme linked immunosorbent assay
Escherichia coli
Humoral immunity
Immune response
Immunization
Immunofluorescence
Immunogenicity
Monkey
Nonhuman
Parasitemia
Plasmodium vivax
Priority journal
Protection
Protein expression
Western blotting
Animals
Aotidae
Immunogenetic processes
Malaria vaccines
Plasmodium vivax
Protozoan proteins
Immune response
Plasmodium vivax
Rhoptry-associated protein
Vaccine candidate
animal
Disease models
dc.subject.keyword.eng.fl_str_mv animal
Disease models
description Rhoptry proteins have been extensively shown to be important in invasion and parasitophorous vacuole (PV) formation. This work evaluates the immunogenicity and protective efficacy of Plasmodium vivax RAP2 in the non-human Aotus primate model, when expressed as a recombinant molecule in E. coli and formulated in Freund and Alum hydroxide adjuvants. Our results show that rPvRAP2 is immunogenic in both formulations, finding a trend of higher cytokine levels in immunized monkeys, specially in IL-4 levels (using Freund's adjuvant) and IL-5 (using Alum hydroxide). RAP2 is suggested as a P. vivax-vaccine candidate since immunized monkeys exhibited lower parasitemias than control groups after being experimentally challenged with the P. vivax VCG-I strain. © 2009 Elsevier Ltd. All rights reserved.
publishDate 2009
dc.date.created.spa.fl_str_mv 2009
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:02:07Z
dc.date.available.none.fl_str_mv 2020-05-26T00:02:07Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.vaccine.2009.02.083
dc.identifier.issn.none.fl_str_mv 0264410X
13588745
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23450
url https://doi.org/10.1016/j.vaccine.2009.02.083
https://repository.urosario.edu.co/handle/10336/23450
identifier_str_mv 0264410X
13588745
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 2876
dc.relation.citationIssue.none.fl_str_mv No. 21
dc.relation.citationStartPage.none.fl_str_mv 2870
dc.relation.citationTitle.none.fl_str_mv Vaccine
dc.relation.citationVolume.none.fl_str_mv Vol. 27
dc.relation.ispartof.spa.fl_str_mv Vaccine, ISSN:0264410X, 13588745, Vol.27, No.21 (2009); pp. 2870-2876
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-64449088031&doi=10.1016%2fj.vaccine.2009.02.083&partnerID=40&md5=b9f51df638ac77777d83049a0da4c0e4
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/9f625b72-8201-4c07-8d47-53c05e80084b/download
https://repository.urosario.edu.co/bitstreams/7e1a39a1-ee4c-47ef-900c-6a51ce58c75c/download
https://repository.urosario.edu.co/bitstreams/bfd7f937-4a07-46f3-852b-dfa00a100d1c/download
bitstream.checksum.fl_str_mv 0b2501e83b871d4268fbae425ac4ecbb
cd63baecec7fbd92d92b3778fb6635e4
345ef783fd0d66617288ac6db103a580
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390610613174272